Esperion Therapeutics
ESPR
ESPR
84 hedge funds and large institutions have $398M invested in Esperion Therapeutics in 2014 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 28 increasing their positions, 12 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
68% more funds holding
Funds holding: 50 → 84 (+34)
23% more call options, than puts
Call options by funds: $2.82M | Put options by funds: $2.29M
Holders
84
Holding in Top 10
3
Calls
$2.82M
Puts
$2.29M
Top Buyers
| 1 | +$53.3M | |
| 2 | +$21.4M | |
| 3 | +$19.4M | |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$16.9M |
| 5 |
PA
Perceptive Advisors
New York
|
+$12.2M |
Top Sellers
| 1 | -$5.31M | |
| 2 | -$2.67M | |
| 3 | -$1.74M | |
| 4 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$1.42M |
| 5 |
Jane Street
New York
|
-$1.32M |